According to a market report by Lucintel, the future of the global pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets. The global pharmaceutical contract manufacturing market is expected to reach an estimated $396 billion by 2035 with a CAGR of 6.9% from 2026 to 2035. The major drivers for this market are the growing demand for faster drug production & delivery, the rising need for advanced manufacturing technologies, and the increasing outsourcing by pharmaceutical companies to reduce costs.
A more than 150-page report to understand trends, opportunity and forecast in pharmaceutical contract manufacturing market to 2035 by services (manufacturing, drug development, and biologics manufacturing), end use (big pharmaceutical, small & medium-sized pharmaceutical, generic pharmaceutical, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the Services category, biologic manufacturing is expected to witness the highest growth over the forecast period due to the increasing demand for biologics production outsourcing.
Within the end use category, big pharmaceutical is expected to witness the highest growth due to the rising drug development pipelines and biologics investments.
Download sample by clicking on pharmaceutical contract manufacturing market
In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the rapid pharmaceutical manufacturing expansion and cost advantages.
Thermo Fisher Scientific, Catalent, Lonza, Almac Group, Recipharm, Patheon, Grifols International are the major suppliers in the pharmaceutical contract manufacturing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] to get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Semiconductor Molding System Market
Semiconductor Plating Chemical Market
Signal Adapter Market
Simethicone Market
SiN AMB Substrate Market